Research Roundup: Novel antibiotic research, RSV vaccine efficacy, HPV testing access agreement
In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.
Sign up to receive news and updates from GHTC.
In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.
Twenty years after the approval of the first HPV vaccine, a game-changing tool that has helped dramatically reduce rates of HPV infection and cervical cancer around the world, researchers are now developing new tools to address remaining gaps in cervical cancer screening, diagnosis, and care.
A new opinion piece cowritten by former Florida congressman Ted Yoho and GHTC Executive Director Dr. Kristie Mikus focuses on how investments in global health research and development (R&D) deliver for Floridians and other Americans, as well as people around the world.
Scientific efficacy alone is not enough to ensure acceptance of new health interventions. Learn why and how researchers are increasingly partnering with communities to design and develop health solutions that people will trust and use.